Anbio Biotechnology (NNNN) Short-term Investments (2023 - 2025)

Historic Short-term Investments for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $8080.5 billion.

  • Anbio Biotechnology's Short-term Investments changed N/A to $8080.5 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $8080.5 billion, marking a year-over-year change of. This contributed to the annual value of $1294.0 for FY2024, which is 6034.32% down from last year.
  • According to the latest figures from Q2 2025, Anbio Biotechnology's Short-term Investments is $8080.5 billion.
  • In the past 5 years, Anbio Biotechnology's Short-term Investments ranged from a high of $8080.5 billion in Q2 2025 and a low of $1294.0 during Q4 2024
  • Its 3-year average for Short-term Investments is $2693.5 billion, with a median of $3263.0 in 2023.
  • The largest annual percentage gain for Anbio Biotechnology's Short-term Investments in the last 5 years was 6034.32% (2024), contrasted with its biggest fall of 6034.32% (2024).
  • Anbio Biotechnology's Short-term Investments (Quarter) stood at $3263.0 in 2023, then tumbled by 60.34% to $1294.0 in 2024, then skyrocketed by 624459196190.57% to $8080.5 billion in 2025.
  • Its last three reported values are $8080.5 billion in Q2 2025, $1294.0 for Q4 2024, and $3263.0 during Q4 2023.